258 related articles for article (PubMed ID: 26192147)
1. Association Between Transjugular Intrahepatic Portosystemic Shunt and Survival in Patients With Cirrhosis.
Berry K; Lerrigo R; Liou IW; Ioannou GN
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):118-23. PubMed ID: 26192147
[TBL] [Abstract][Full Text] [Related]
2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
Tan HK; James PD; Sniderman KW; Wong F
J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
[TBL] [Abstract][Full Text] [Related]
5. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
7. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
Am J Gastroenterol; 2010 Mar; 105(3):635-41. PubMed ID: 19904245
[TBL] [Abstract][Full Text] [Related]
10. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
Wei J; Li H; Li C
J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
[TBL] [Abstract][Full Text] [Related]
11. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis.
Berry K; Taylor J; Liou IW; Ioannou GN
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):585-93. PubMed ID: 25459555
[TBL] [Abstract][Full Text] [Related]
12. A Standardized Assessment of Functional Disability Predicts 1-year Mortality in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
Grunwald D; Tapper EB; Jiang ZG; Ahmed M; Malik R
J Clin Gastroenterol; 2016 Jan; 50(1):75-9. PubMed ID: 25984975
[TBL] [Abstract][Full Text] [Related]
13. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
14. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.
Campos S; Gomes D; Sofia C
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):661-6. PubMed ID: 27002676
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.
Heinzow HS; Lenz P; Köhler M; Reinecke F; Ullerich H; Domschke W; Domagk D; Meister T
World J Gastroenterol; 2012 Oct; 18(37):5211-8. PubMed ID: 23066315
[TBL] [Abstract][Full Text] [Related]
16. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study.
Huang M; Feng Z; Ji D; Cao Y; Shi X; Chen P; Wang P; Tang M; Liu K
Cytotherapy; 2014 Nov; 16(11):1575-1583. PubMed ID: 25287603
[TBL] [Abstract][Full Text] [Related]
17. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation.
King A; Masterton G; Gunson B; Olliff S; Redhead D; Mangat K; Oniscu G; Hayes P; Tripathi D
Liver Transpl; 2011 Jul; 17(7):771-8. PubMed ID: 21714062
[TBL] [Abstract][Full Text] [Related]
18. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
[TBL] [Abstract][Full Text] [Related]
20. [Indicators for longterm survival after the transjugular portosystemic intrahepatic shunt procedure].
Kirchhoff TD; Rosenthal H; Merkesdal S; Ockenga J; Manns MP; Galanski M; Caselitz M
Radiologe; 2002 Sep; 42(9):745-52. PubMed ID: 12244477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]